Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_1
5
83%
Ph phase_2
1
17%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
5(83.3%)
Phase 2Efficacy & side effects
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (83.3%)
Phase 21 (16.7%)

Trials by Status

completed467%
active_not_recruiting233%

Recent Activity

2 active trials
Showing 5 of 6
completedphase_1

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

NCT07266818
active_not_recruitingphase_1

A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)

NCT07334860
active_not_recruitingphase_2

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

NCT06721156
completedphase_1

Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)

NCT06285240
completedphase_1

A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)

NCT06703463
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07266818Phase 1

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

Completed
NCT07334860Phase 1

A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)

Active Not Recruiting
NCT06721156Phase 2

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Active Not Recruiting
NCT06285240Phase 1

Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)

Completed
NCT06703463Phase 1

A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006)

Completed
NCT06625840Phase 1

A Study of MK-1167 in Healthy Elderly Participants (MK-1167-004)

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6